ENDRA Life Sciences (NDRA) Amortizatization of Intangibles (2017 - 2022)
ENDRA Life Sciences (NDRA) posted quarterly Amortizatization of Intangibles of -$35640.0 for Q4 2022, down 9.97% year-over-year from -$39586.6 in Q4 2021, and down 2.42% quarter-over-quarter from -$34799.0 in Q3 2022.
ENDRA Life Sciences (NDRA) Amortizatization of Intangibles (2017 - 2022) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Amortizatization of Intangibles for 6 consecutive years, with -$35640.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Amortizatization of Intangibles fell 9.97% year-over-year to -$35640.0; the TTM figure through Dec 2022 stood at $505816.0 (up 74.93% YoY), while the FY2022 annual figure was $505816.0, down 21.39% from the prior year.
- Amortizatization of Intangibles slipped to -$35640.0 in Q4 2022 per NDRA's latest filing, from -$34799.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $728417.0 in Q3 2019 and bottomed at -$693983.0 in Q4 2019.
- Historically, Amortizatization of Intangibles has averaged $83458.3 across 5 years, with a median of $4840.0 in 2018.
- Annual changes were most pronounced in 2018 — Amortizatization of Intangibles tumbled 153.89% — and 2020, when it surged 115.36%.
- ENDRA Life Sciences' Amortizatization of Intangibles stood at -$383428.0 in 2018, then tumbled by 80.99% to -$693983.0 in 2019, then surged by 115.36% to $106586.0 in 2020, then plunged by 130.41% to -$32409.0 in 2021, then dropped by 9.97% to -$35640.0 in 2022.
- Business Quant data shows NDRA's Amortizatization of Intangibles at -$35640.0 in Q4 2022, -$34799.0 in Q3 2022, and -$33979.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | - |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | - |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -35,640.00 |
| Dec 31, 2022 | -35,640.00 |
| Sep 30, 2022 | -34,799.00 |
| Sep 30, 2022 | -34,799.00 |
| Jun 30, 2022 | -33,979.00 |
| Jun 30, 2022 | -33,979.00 |
| Mar 31, 2022 | 610,234.00 |
| Mar 31, 2022 | 610,234.00 |
| Dec 31, 2021 | -32,409.00 |
| Dec 31, 2021 | -32,409.00 |
| Mar 31, 2021 | 321,563.00 |
| Mar 31, 2021 | 321,563.00 |
| Dec 31, 2020 | 106,586.00 |
| Dec 31, 2020 | 106,586.00 |
| Jun 30, 2020 | 3,858.00 |
| Jun 30, 2020 | 3,858.00 |
| Mar 31, 2020 | 228,568.00 |
| Mar 31, 2020 | 228,568.00 |
| Dec 31, 2019 | -693,983.00 |
| Dec 31, 2019 | -693,983.00 |